Financial results - D.D. DRUGS SRL

Financial Summary - D.d. Drugs Srl
Unique identification code: 38102458
Registration number: J2017002371085
Nace: 4773
Sales - Ron
203.237
Net Profit - Ron
25.455
Employees
2
Open Account
Company D.d. Drugs Srl with Fiscal Code 38102458 recorded a turnover of 2024 of 203.237, with a net profit of 25.455 and having an average number of employees of 2. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - D.d. Drugs Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - 3.901 128.386 192.688 158.077 132.263 162.818 193.254 203.237
Total Income - EUR - - 4.055 128.544 192.920 158.608 133.238 164.926 195.929 204.196
Total Expenses - EUR - - 5.383 110.441 177.958 156.168 148.666 183.326 196.904 173.467
Gross Profit/Loss - EUR - - -1.327 18.103 14.962 2.440 -15.429 -18.399 -974 30.730
Net Profit/Loss - EUR - - -1.370 16.815 13.033 1.201 -16.668 -20.048 -2.934 25.455
Employees - - 1 1 1 1 2 2 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 5.8%, from 193.254 euro in the year 2023, to 203.237 euro in 2024. The Net Profit increased by 25.455 euro, from 0 euro in 2023, to 25.455 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - D.d. Drugs Srl

Rating financiar

Financial Rating -
D.D. DRUGS SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
D.d. Drugs Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
D.d. Drugs Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
D.d. Drugs Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - D.d. Drugs Srl - CUI 38102458

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - 0 0 57.855 47.682 36.351 26.756 16.824 7.097
Current Assets - - 7.255 35.637 41.346 48.431 34.005 51.018 38.379 47.515
Inventories - - 5.171 20.888 13.996 24.983 15.877 14.342 21.520 27.073
Receivables - - 0 4.577 4.646 7.937 15.864 25.659 11.431 11.890
Cash - - 2.084 10.172 22.705 15.511 2.265 11.017 5.429 8.553
Shareholders Funds - - -1.326 15.513 28.246 28.912 11.603 -8.409 -11.317 12.961
Social Capital - - 44 43 42 41 40 41 40 40
Debts - - 8.582 20.124 71.046 70.406 58.753 86.183 66.521 41.651
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 47.515 euro in 2024 which includes Inventories of 27.073 euro, Receivables of 11.890 euro and cash availability of 8.553 euro.
The company's Equity was valued at 12.961 euro, while total Liabilities amounted to 41.651 euro. Equity increased by 24.215 euro, from -11.317 euro in 2023, to 12.961 in 2024.

Risk Reports Prices

Reviews - D.d. Drugs Srl

Comments - D.d. Drugs Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.